Christopher A. Kuebler
Known title: DirectorCIK: 0001229877
Associated companies
Transaction History
| WAT | ▲ Buy | Option Exercise | 3,626 | $495K | 8/6/2026 | View on chart |
| WAT | ▼ Sell | Open Market | 3,626 | $1.4M | 8/6/2026 | View on chart |
| WAT | ▲ Buy | Grant | 23 | $0 | 2/25/2026 | View on chart |
| WAT | ▲ Buy | Grant | 307 | $0 | 1/2/2026 | View on chart |
| WAT | ▼ Sell | Tax Withholding | 1,318 | $490K | 11/5/2025 | View on chart |
| WAT | ▲ Buy | Option Exercise | 3,761 | $490K | 11/5/2025 | View on chart |
| WAT | ▲ Buy | Grant | 319 | $0 | 1/2/2025 | View on chart |
| WAT | ▲ Buy | Option Exercise | 4,000 | $456K | 5/15/2024 | View on chart |
| WAT | ▼ Sell | Open Market | 4,000 | $1.4M | 5/15/2024 | View on chart |
| WAT | ▲ Buy | Grant | 334 | $0 | 1/2/2024 | View on chart |
| WAT | ▲ Buy | Option Exercise | 4,000 | $397K | 8/4/2023 | View on chart |
| WAT | ▼ Sell | Open Market | 4,000 | $1.2M | 8/4/2023 | View on chart |
| WAT | ▲ Buy | Grant | 318 | $0 | 1/3/2023 | View on chart |
| WAT | ▲ Buy | Option Exercise | 4,000 | $355K | 5/19/2022 | View on chart |
| WAT | ▼ Sell | Open Market | 4,000 | $1.3M | 5/19/2022 | View on chart |
| WAT | ▲ Buy | Grant | 301 | $0 | 1/3/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Waters Launches AI Link for LC-MS Workflows
Waters Corporation introduced AI Link, a tool designed to advance AI-enabled LC-MS workflows from research to release. This product launch highlights the company's focus on integrating artificial intelligence into its laboratory solutions. Additionally, TD Cowen raised its price target to $515, reflecting continued analyst interest in the stock's potential.
Waters Launches AI Link for LC-MS Workflows. Waters Corporation introduced AI Link, a tool designed to advance AI-enabled LC-MS workflows from research to release. This product launch highlights the company's focus on integrating artificial intelligence into its laboratory solutions. Additionally, TD Cowen raised its price target to $515, reflecting continued analyst interest in the stock's potential.